Intervention

thiotepa

ClinicalTrials.gov intervention label

Clinical trials23

Recruiting0

Common conditions16

Lead sponsors shown15

Clinical trials

23 shown

Combination Chemotherapy With or Without Trastuzumab Followed By an Autologous Stem Cell Transplant and Radiation Therapy in Treating Patients With Stage III or Stage IV Breast CancerNCT00182793 · 2005-07-01

Chemotherapy and Peripheral Stem Cell Transplantation Followed by Trastuzumab in Treating Women With Metastatic Breast CancerNCT00006123 · 2000-07-01

Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Chemotherapy Alone in Treating Women With Stage IV Breast CancerNCT00012311 · 2000-01-01

Chemotherapy, Filgrastim, and Stem Cell Transplantation With Radiation Therapy in Treating Patients With Stage III or Stage IV Breast CancerNCT00004172 · 1999-10-01

Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Women With Metastatic Breast CancerNCT00004900 · 1999-10-01

Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Women With Metastatic Breast CancerNCT00004906 · 1999-10-01

Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation in Treating Patients With Advanced Breast CancerNCT00004174 · 1999-10-01

Combination Chemotherapy in Treating Patients With High-Risk Breast CancerNCT00004092 · 1999-05-01

Chemotherapy Plus Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Solid TumorsNCT00003899 · 1999-01-01

Standard Chemotherapy Compared With High-Dose Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Women With Advanced or Inflammatory Breast CancerNCT00003680 · 1998-11-01

Peripheral Stem Cell Transplantation With or Without Stromagen Following Chemotherapy in Treating Women With Metastatic Breast CancerNCT00003877 · 1998-09-01

Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage II or Stage IIIA Breast CancerNCT00003972 · 1998-07-01

Combination Chemotherapy and Peripheral Blood Stem Cell Transplant Followed By Aldesleukin and Sargramostim in Treating Patients With Inflammatory Stage IIIB or Metastatic Stage IV Breast CancerNCT00003199 · 1997-11-01

High-Dose Chemotherapy and Autologous Blood Cell Transplantation in Treating Patients With Primary, Locally Advanced, or Stage IV Breast CancerNCT00003068 · 1997-06-01

Repeated Bone Marrow Transplantation in Treating Women With Advanced Breast CancerNCT00003086 · 1997-03-01

S9623, Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Women With Breast CancerNCT00002772 · 1996-07-01

Biological Therapy in Treating Women With Metastatic Breast CancerNCT00002780 · 1996-05-01

Comparison of Biological Therapies Following Combination Chemotherapy and Bone Marrow or Peripheral Stem Cell Transplantation in Women With Stage II or Stage III Breast CancerNCT00008203 · 1996-05-01

Standard Chemotherapy Compared With High-Dose Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Women With Breast CancerNCT00002755 · 1995-11-01

Biological Therapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Breast CancerNCT00002616 · 1995-02-01

High Dose Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Therapy in Treating Women With Locally Recurrent or Metastatic Breast CancerNCT00002870 · 1994-12-01

Sequential High-Dose Chemotherapy and Stem Cell Transplantation in Treating Patients With Chemotherapy-Sensitive Metastatic Breast CancerNCT00002680 · 1994-02-01

High-Dose Chemotherapy, Total-Body Irradiation, and Autologous Stem Cell Transplantation or Bone Marrow Transplantation in Treating Patients With Hematologic Cancer or Solid TumorsNCT00060255 · 1991-12-01

Common conditions

Breast Cancer21 Unspecified Adult Solid Tumor, Protocol Specific2 Drug/Agent Toxicity by Tissue/Organ1 Estrogen Receptor-negative Breast Cancer1 Estrogen Receptor-positive Breast Cancer1 Inflammatory Breast Cancer1 Leukemia1 Lymphoma1 Male Breast Cancer1 Multiple Myeloma and Plasma Cell Neoplasm1 Progesterone Receptor-negative Breast Cancer1 Progesterone Receptor-positive Breast Cancer1 Stage IIIB Breast Cancer1 Stage IV Breast Cancer1 Testicular Germ Cell Tumor1 Unspecified Childhood Solid Tumor, Protocol Specific1

Leading sponsors

Fred Hutchinson Cancer Center3 City of Hope Medical Center2 Hackensack Meridian Health2 Herbert Irving Comprehensive Cancer Center2 Northwestern University2 Roswell Park Cancer Institute2 Scottish Cancer Therapy Network2 Beth Israel Deaconess Medical Center1 Louisiana State University Health Sciences Center Shreveport1 St. Luke's Medical Center1 SWOG Cancer Research Network1 UNICANCER1 University of Arizona1 University of Illinois at Chicago1 Yale University1

Trial status mix

COMPLETED16

UNKNOWN4

TERMINATED2

WITHDRAWN1

Phase mix

PHASE214

PHASE17

PHASE36

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.